Description
Description
This page contains brief details about the drug gefitinib, it’s indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Date of Approval
Gefitinib was first approved by the U.S. FDA on May 03, 2003, for advanced non-small-cell lung cancer (NSCLC) treatment.
Mechanism of Action of Gefitinib
It is an anilinoquinazoline derivative interact with a kinase inhibitor that inhibits an abnormal protein called the epidermal growth factor receptor (EGFR). This helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.
Uses of Gefitinib
Gefitinib has been developed to treat non-small cell lung cancer in adults.
Gefitinib Dosage available
The medicine will be prescribed to you by a healthcare professional in a hospital setting. Gefitinib is available as a tablet to be taken with or without food, as directed by your healthcare provider. The usual recommended dosage is 250 mg tablet once daily. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Gefitinib tablet at the same time every day.
